 | • レポートコード：MRC2Q12-17043 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、血管塞栓剤のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 血管塞栓剤のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 血管塞栓剤の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 血管塞栓剤のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの血管塞栓剤の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の血管塞栓剤の売上および2028年までの予測に焦点を当てています。 血管塞栓剤のグローバル主要企業には、Abbott、Boston Scientific Corporation、Cook Medical LLC、Johnson & Johnson、Medtronic、Acandis GmbH、SSEM Mthembu Medical (Pty) Ltd、Balt USA LLC、Stryker、Guerbet LLC、Terumo Corporation、Penumbra、Grandpharma (Sirtex)、Merit Medical、Siemens Healthineers (Varian)、Jiangsu Hengrui Medicine、Kaneka、Meril Life Sciences、Peijia Medical、Wallaby Medical、MicroPort Scientific Corporation、Weihai Visee Medical Devices、Beijing Taijieweiye Technologyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 血管塞栓剤市場は、タイプとアプリケーションによって区分されます。世界の血管塞栓剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 微粒子、液体塞栓剤、塞栓コイル、塞栓プラグシステム、着脱式バルーン、その他 【アプリケーション別セグメント】 病院・診療所、外来手術センター、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 血管塞栓剤製品概要 - タイプ別市場（微粒子、液体塞栓剤、塞栓コイル、塞栓プラグシステム、着脱式バルーン、その他） - アプリケーション別市場（病院・診療所、外来手術センター、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の血管塞栓剤販売量予測2017-2028 - 世界の血管塞栓剤売上予測2017-2028 - 血管塞栓剤の地域別販売量 - 血管塞栓剤の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別血管塞栓剤販売量 - 主要メーカー別血管塞栓剤売上 - 主要メーカー別血管塞栓剤価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（微粒子、液体塞栓剤、塞栓コイル、塞栓プラグシステム、着脱式バルーン、その他） - 血管塞栓剤のタイプ別販売量 - 血管塞栓剤のタイプ別売上 - 血管塞栓剤のタイプ別価格 ・アプリケーション別市場規模（病院・診療所、外来手術センター、その他） - 血管塞栓剤のアプリケーション別販売量 - 血管塞栓剤のアプリケーション別売上 - 血管塞栓剤のアプリケーション別価格 ・北米市場 - 北米の血管塞栓剤市場規模（タイプ別、アプリケーション別） - 主要国別の血管塞栓剤市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの血管塞栓剤市場規模（タイプ別、アプリケーション別） - 主要国別の血管塞栓剤市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の血管塞栓剤市場規模（タイプ別、アプリケーション別） - 主要国別の血管塞栓剤市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の血管塞栓剤市場規模（タイプ別、アプリケーション別） - 主要国別の血管塞栓剤市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの血管塞栓剤市場規模（タイプ別、アプリケーション別） - 主要国別の血管塞栓剤市場規模（トルコ、サウジアラビア） ・企業情報 Abbott、Boston Scientific Corporation、Cook Medical LLC、Johnson & Johnson、Medtronic、Acandis GmbH、SSEM Mthembu Medical (Pty) Ltd、Balt USA LLC、Stryker、Guerbet LLC、Terumo Corporation、Penumbra、Grandpharma (Sirtex)、Merit Medical、Siemens Healthineers (Varian)、Jiangsu Hengrui Medicine、Kaneka、Meril Life Sciences、Peijia Medical、Wallaby Medical、MicroPort Scientific Corporation、Weihai Visee Medical Devices、Beijing Taijieweiye Technology ・産業チェーン及び販売チャネル分析 - 血管塞栓剤の産業チェーン分析 - 血管塞栓剤の原材料 - 血管塞栓剤の生産プロセス - 血管塞栓剤の販売及びマーケティング - 血管塞栓剤の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 血管塞栓剤の産業動向 - 血管塞栓剤のマーケットドライバー - 血管塞栓剤の課題 - 血管塞栓剤の阻害要因 ・主な調査結果 |
Playing a more vital role in the field of medicine than ever before, embolotherapy is a type of endovascular treatment that aims to occlude abnormal blood vessels in order to control bleeding, close fistulae or arteriovenous malformations, devascularise organs, reduce tumours and much more. This report focus on Blood Vessels Embolic Agents market.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Blood Vessels Embolic Agents estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Blood Vessels Embolic Agents is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Blood Vessels Embolic Agents is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Blood Vessels Embolic Agents is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Blood Vessels Embolic Agents include Abbott, Boston Scientific Corporation, Cook Medical LLC, Johnson & Johnson, Medtronic, Acandis GmbH, SSEM Mthembu Medical (Pty) Ltd, Balt USA LLC and Stryker, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Blood Vessels Embolic Agents companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Blood Vessels Embolic Agents market. Further, it explains the major drivers and regional dynamics of the global Blood Vessels Embolic Agents market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Abbott
Boston Scientific Corporation
Cook Medical LLC
Johnson & Johnson
Medtronic
Acandis GmbH
SSEM Mthembu Medical (Pty) Ltd
Balt USA LLC
Stryker
Guerbet LLC
Terumo Corporation
Penumbra
Grandpharma (Sirtex)
Merit Medical
Siemens Healthineers (Varian)
Jiangsu Hengrui Medicine
Kaneka
Meril Life Sciences
Peijia Medical
Wallaby Medical
MicroPort Scientific Corporation
Weihai Visee Medical Devices
Beijing Taijieweiye Technology
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Blood Vessels Embolic Agents Segment by Type
Microsphere
Liquid Embolics Agents
Embolic Coils
Embolic Plug Systems
Detachable Balloons
Others
Blood Vessels Embolic Agents Segment by Application
Hospital & Clinic
Ambulatory Surgical Center
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Blood Vessels Embolic Agents market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Blood Vessels Embolic Agents market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Blood Vessels Embolic Agents, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Blood Vessels Embolic Agents, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Blood Vessels Embolic Agents revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Blood Vessels Embolic Agents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Blood Vessels Embolic Agents revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott, Boston Scientific Corporation, Cook Medical LLC, Johnson & Johnson, Medtronic, Acandis GmbH, SSEM Mthembu Medical (Pty) Ltd, Balt USA LLC and Stryker, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Blood Vessels Embolic Agents in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Vessels Embolic Agents companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blood Vessels Embolic Agents revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Vessels Embolic Agents Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Microsphere
1.2.3 Liquid Embolics Agents
1.2.4 Embolic Coils
1.2.5 Embolic Plug Systems
1.2.6 Detachable Balloons
1.2.7 Others
1.3 Market by Application
1.3.1 Global Blood Vessels Embolic Agents Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital & Clinic
1.3.3 Ambulatory Surgical Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Blood Vessels Embolic Agents Market Perspective (2017-2028)
2.2 Blood Vessels Embolic Agents Growth Trends by Region
2.2.1 Blood Vessels Embolic Agents Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Blood Vessels Embolic Agents Historic Market Size by Region (2017-2022)
2.2.3 Blood Vessels Embolic Agents Forecasted Market Size by Region (2023-2028)
2.3 Blood Vessels Embolic Agents Market Dynamics
2.3.1 Blood Vessels Embolic Agents Industry Trends
2.3.2 Blood Vessels Embolic Agents Market Drivers
2.3.3 Blood Vessels Embolic Agents Market Challenges
2.3.4 Blood Vessels Embolic Agents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Vessels Embolic Agents Players by Revenue
3.1.1 Global Top Blood Vessels Embolic Agents Players by Revenue (2017-2022)
3.1.2 Global Blood Vessels Embolic Agents Revenue Market Share by Players (2017-2022)
3.2 Global Blood Vessels Embolic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Blood Vessels Embolic Agents Revenue
3.4 Global Blood Vessels Embolic Agents Market Concentration Ratio
3.4.1 Global Blood Vessels Embolic Agents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Vessels Embolic Agents Revenue in 2021
3.5 Blood Vessels Embolic Agents Key Players Head office and Area Served
3.6 Key Players Blood Vessels Embolic Agents Product Solution and Service
3.7 Date of Enter into Blood Vessels Embolic Agents Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Vessels Embolic Agents Breakdown Data by Type
4.1 Global Blood Vessels Embolic Agents Historic Market Size by Type (2017-2022)
4.2 Global Blood Vessels Embolic Agents Forecasted Market Size by Type (2023-2028)
5 Blood Vessels Embolic Agents Breakdown Data by Application
5.1 Global Blood Vessels Embolic Agents Historic Market Size by Application (2017-2022)
5.2 Global Blood Vessels Embolic Agents Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Blood Vessels Embolic Agents Market Size (2017-2028)
6.2 North America Blood Vessels Embolic Agents Market Size by Type
6.2.1 North America Blood Vessels Embolic Agents Market Size by Type (2017-2022)
6.2.2 North America Blood Vessels Embolic Agents Market Size by Type (2023-2028)
6.2.3 North America Blood Vessels Embolic Agents Market Share by Type (2017-2028)
6.3 North America Blood Vessels Embolic Agents Market Size by Application
6.3.1 North America Blood Vessels Embolic Agents Market Size by Application (2017-2022)
6.3.2 North America Blood Vessels Embolic Agents Market Size by Application (2023-2028)
6.3.3 North America Blood Vessels Embolic Agents Market Share by Application (2017-2028)
6.4 North America Blood Vessels Embolic Agents Market Size by Country
6.4.1 North America Blood Vessels Embolic Agents Market Size by Country (2017-2022)
6.4.2 North America Blood Vessels Embolic Agents Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Blood Vessels Embolic Agents Market Size (2017-2028)
7.2 Europe Blood Vessels Embolic Agents Market Size by Type
7.2.1 Europe Blood Vessels Embolic Agents Market Size by Type (2017-2022)
7.2.2 Europe Blood Vessels Embolic Agents Market Size by Type (2023-2028)
7.2.3 Europe Blood Vessels Embolic Agents Market Share by Type (2017-2028)
7.3 Europe Blood Vessels Embolic Agents Market Size by Application
7.3.1 Europe Blood Vessels Embolic Agents Market Size by Application (2017-2022)
7.3.2 Europe Blood Vessels Embolic Agents Market Size by Application (2023-2028)
7.3.3 Europe Blood Vessels Embolic Agents Market Share by Application (2017-2028)
7.4 Europe Blood Vessels Embolic Agents Market Size by Country
7.4.1 Europe Blood Vessels Embolic Agents Market Size by Country (2017-2022)
7.4.2 Europe Blood Vessels Embolic Agents Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Vessels Embolic Agents Market Size (2017-2028)
8.2 Asia-Pacific Blood Vessels Embolic Agents Market Size by Type
8.2.1 Asia-Pacific Blood Vessels Embolic Agents Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Blood Vessels Embolic Agents Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Blood Vessels Embolic Agents Market Share by Type (2017-2028)
8.3 Asia-Pacific Blood Vessels Embolic Agents Market Size by Application
8.3.1 Asia-Pacific Blood Vessels Embolic Agents Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Blood Vessels Embolic Agents Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Blood Vessels Embolic Agents Market Share by Application (2017-2028)
8.4 Asia-Pacific Blood Vessels Embolic Agents Market Size by Region
8.4.1 Asia-Pacific Blood Vessels Embolic Agents Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Blood Vessels Embolic Agents Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Blood Vessels Embolic Agents Market Size (2017-2028)
9.2 Latin America Blood Vessels Embolic Agents Market Size by Type
9.2.1 Latin America Blood Vessels Embolic Agents Market Size by Type (2017-2022)
9.2.2 Latin America Blood Vessels Embolic Agents Market Size by Type (2023-2028)
9.2.3 Latin America Blood Vessels Embolic Agents Market Share by Type (2017-2028)
9.3 Latin America Blood Vessels Embolic Agents Market Size by Application
9.3.1 Latin America Blood Vessels Embolic Agents Market Size by Application (2017-2022)
9.3.2 Latin America Blood Vessels Embolic Agents Market Size by Application (2023-2028)
9.3.3 Latin America Blood Vessels Embolic Agents Market Share by Application (2017-2028)
9.4 Latin America Blood Vessels Embolic Agents Market Size by Country
9.4.1 Latin America Blood Vessels Embolic Agents Market Size by Country (2017-2022)
9.4.2 Latin America Blood Vessels Embolic Agents Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Vessels Embolic Agents Market Size (2017-2028)
10.2 Middle East & Africa Blood Vessels Embolic Agents Market Size by Type
10.2.1 Middle East & Africa Blood Vessels Embolic Agents Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Blood Vessels Embolic Agents Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Blood Vessels Embolic Agents Market Share by Type (2017-2028)
10.3 Middle East & Africa Blood Vessels Embolic Agents Market Size by Application
10.3.1 Middle East & Africa Blood Vessels Embolic Agents Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Blood Vessels Embolic Agents Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Blood Vessels Embolic Agents Market Share by Application (2017-2028)
10.4 Middle East & Africa Blood Vessels Embolic Agents Market Size by Country
10.4.1 Middle East & Africa Blood Vessels Embolic Agents Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Blood Vessels Embolic Agents Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Blood Vessels Embolic Agents Introduction
11.1.4 Abbott Revenue in Blood Vessels Embolic Agents Business (2017-2022)
11.1.5 Abbott Recent Developments
11.2 Boston Scientific Corporation
11.2.1 Boston Scientific Corporation Company Details
11.2.2 Boston Scientific Corporation Business Overview
11.2.3 Boston Scientific Corporation Blood Vessels Embolic Agents Introduction
11.2.4 Boston Scientific Corporation Revenue in Blood Vessels Embolic Agents Business (2017-2022)
11.2.5 Boston Scientific Corporation Recent Developments
11.3 Cook Medical LLC
11.3.1 Cook Medical LLC Company Details
11.3.2 Cook Medical LLC Business Overview
11.3.3 Cook Medical LLC Blood Vessels Embolic Agents Introduction
11.3.4 Cook Medical LLC Revenue in Blood Vessels Embolic Agents Business (2017-2022)
11.3.5 Cook Medical LLC Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Blood Vessels Embolic Agents Introduction
11.4.4 Johnson & Johnson Revenue in Blood Vessels Embolic Agents Business (2017-2022)
11.4.5 Johnson & Johnson Recent Developments
11.5 Medtronic
11.5.1 Medtronic Company Details
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Blood Vessels Embolic Agents Introduction
11.5.4 Medtronic Revenue in Blood Vessels Embolic Agents Business (2017-2022)
11.5.5 Medtronic Recent Developments
11.6 Acandis GmbH
11.6.1 Acandis GmbH Company Details
11.6.2 Acandis GmbH Business Overview
11.6.3 Acandis GmbH Blood Vessels Embolic Agents Introduction
11.6.4 Acandis GmbH Revenue in Blood Vessels Embolic Agents Business (2017-2022)
11.6.5 Acandis GmbH Recent Developments
11.7 SSEM Mthembu Medical (Pty) Ltd
11.7.1 SSEM Mthembu Medical (Pty) Ltd Company Details
11.7.2 SSEM Mthembu Medical (Pty) Ltd Business Overview
11.7.3 SSEM Mthembu Medical (Pty) Ltd Blood Vessels Embolic Agents Introduction
11.7.4 SSEM Mthembu Medical (Pty) Ltd Revenue in Blood Vessels Embolic Agents Business (2017-2022)
11.7.5 SSEM Mthembu Medical (Pty) Ltd Recent Developments
11.8 Balt USA LLC
11.8.1 Balt USA LLC Company Details
11.8.2 Balt USA LLC Business Overview
11.8.3 Balt USA LLC Blood Vessels Embolic Agents Introduction
11.8.4 Balt USA LLC Revenue in Blood Vessels Embolic Agents Business (2017-2022)
11.8.5 Balt USA LLC Recent Developments
11.9 Stryker
11.9.1 Stryker Company Details
11.9.2 Stryker Business Overview
11.9.3 Stryker Blood Vessels Embolic Agents Introduction
11.9.4 Stryker Revenue in Blood Vessels Embolic Agents Business (2017-2022)
11.9.5 Stryker Recent Developments
11.10 Guerbet LLC
11.10.1 Guerbet LLC Company Details
11.10.2 Guerbet LLC Business Overview
11.10.3 Guerbet LLC Blood Vessels Embolic Agents Introduction
11.10.4 Guerbet LLC Revenue in Blood Vessels Embolic Agents Business (2017-2022)
11.10.5 Guerbet LLC Recent Developments
11.11 Terumo Corporation
11.11.1 Terumo Corporation Company Details
11.11.2 Terumo Corporation Business Overview
11.11.3 Terumo Corporation Blood Vessels Embolic Agents Introduction
11.11.4 Terumo Corporation Revenue in Blood Vessels Embolic Agents Business (2017-2022)
11.11.5 Terumo Corporation Recent Developments
11.12 Penumbra
11.12.1 Penumbra Company Details
11.12.2 Penumbra Business Overview
11.12.3 Penumbra Blood Vessels Embolic Agents Introduction
11.12.4 Penumbra Revenue in Blood Vessels Embolic Agents Business (2017-2022)
11.12.5 Penumbra Recent Developments
11.13 Grandpharma (Sirtex)
11.13.1 Grandpharma (Sirtex) Company Details
11.13.2 Grandpharma (Sirtex) Business Overview
11.13.3 Grandpharma (Sirtex) Blood Vessels Embolic Agents Introduction
11.13.4 Grandpharma (Sirtex) Revenue in Blood Vessels Embolic Agents Business (2017-2022)
11.13.5 Grandpharma (Sirtex) Recent Developments
11.14 Merit Medical
11.14.1 Merit Medical Company Details
11.14.2 Merit Medical Business Overview
11.14.3 Merit Medical Blood Vessels Embolic Agents Introduction
11.14.4 Merit Medical Revenue in Blood Vessels Embolic Agents Business (2017-2022)
11.14.5 Merit Medical Recent Developments
11.15 Siemens Healthineers (Varian)
11.15.1 Siemens Healthineers (Varian) Company Details
11.15.2 Siemens Healthineers (Varian) Business Overview
11.15.3 Siemens Healthineers (Varian) Blood Vessels Embolic Agents Introduction
11.15.4 Siemens Healthineers (Varian) Revenue in Blood Vessels Embolic Agents Business (2017-2022)
11.15.5 Siemens Healthineers (Varian) Recent Developments
11.16 Jiangsu Hengrui Medicine
11.16.1 Jiangsu Hengrui Medicine Company Details
11.16.2 Jiangsu Hengrui Medicine Business Overview
11.16.3 Jiangsu Hengrui Medicine Blood Vessels Embolic Agents Introduction
11.16.4 Jiangsu Hengrui Medicine Revenue in Blood Vessels Embolic Agents Business (2017-2022)
11.16.5 Jiangsu Hengrui Medicine Recent Developments
11.17 Kaneka
11.17.1 Kaneka Company Details
11.17.2 Kaneka Business Overview
11.17.3 Kaneka Blood Vessels Embolic Agents Introduction
11.17.4 Kaneka Revenue in Blood Vessels Embolic Agents Business (2017-2022)
11.17.5 Kaneka Recent Developments
11.18 Meril Life Sciences
11.18.1 Meril Life Sciences Company Details
11.18.2 Meril Life Sciences Business Overview
11.18.3 Meril Life Sciences Blood Vessels Embolic Agents Introduction
11.18.4 Meril Life Sciences Revenue in Blood Vessels Embolic Agents Business (2017-2022)
11.18.5 Meril Life Sciences Recent Developments
11.19 Peijia Medical
11.19.1 Peijia Medical Company Details
11.19.2 Peijia Medical Business Overview
11.19.3 Peijia Medical Blood Vessels Embolic Agents Introduction
11.19.4 Peijia Medical Revenue in Blood Vessels Embolic Agents Business (2017-2022)
11.19.5 Peijia Medical Recent Developments
11.20 Wallaby Medical
11.20.1 Wallaby Medical Company Details
11.20.2 Wallaby Medical Business Overview
11.20.3 Wallaby Medical Blood Vessels Embolic Agents Introduction
11.20.4 Wallaby Medical Revenue in Blood Vessels Embolic Agents Business (2017-2022)
11.20.5 Wallaby Medical Recent Developments
11.21 MicroPort Scientific Corporation
11.21.1 MicroPort Scientific Corporation Company Details
11.21.2 MicroPort Scientific Corporation Business Overview
11.21.3 MicroPort Scientific Corporation Blood Vessels Embolic Agents Introduction
11.21.4 MicroPort Scientific Corporation Revenue in Blood Vessels Embolic Agents Business (2017-2022)
11.21.5 MicroPort Scientific Corporation Recent Developments
11.22 Weihai Visee Medical Devices
11.22.1 Weihai Visee Medical Devices Company Details
11.22.2 Weihai Visee Medical Devices Business Overview
11.22.3 Weihai Visee Medical Devices Blood Vessels Embolic Agents Introduction
11.22.4 Weihai Visee Medical Devices Revenue in Blood Vessels Embolic Agents Business (2017-2022)
11.22.5 Weihai Visee Medical Devices Recent Developments
11.23 Beijing Taijieweiye Technology
11.23.1 Beijing Taijieweiye Technology Company Details
11.23.2 Beijing Taijieweiye Technology Business Overview
11.23.3 Beijing Taijieweiye Technology Blood Vessels Embolic Agents Introduction
11.23.4 Beijing Taijieweiye Technology Revenue in Blood Vessels Embolic Agents Business (2017-2022)
11.23.5 Beijing Taijieweiye Technology Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer